[29-412-pm] Antibacterial, antiviral and antifungal agents 2/Vaccines and bioactive agents

[29-412-pm21S] Evaluation of the vaccine potential of replication-incompetent Ebola virus

○Sara Yoshimoto¹, Makoto Kuroda², Shintaro Shichinohe¹, Itsuki Anzai^1,3, Kosuke Takada¹, Ayato Takada⁴, Peter Halfmann², Yoshihiro Kawaoka^2,5,6,7, Tokiko Watanabe^1,3,8 (1. RIMD, Osaka Univ., 2. Influenza Research Institute, University of Wisconsin-Madison, 3. CiDER, Osaka Univ., 4. IIZC, Hokkaido Univ., 5. IMSUT, Tokyo Univ., 6. NCGM, 7. UTOPIA, Tokyo Univ., 8. CAMad)